Literature DB >> 10616848

Trends in mortality on peritoneal dialysis: Canada, 1981-1997.

Douglas E Schaubel1, Stanley S A Fenton2,3.   

Abstract

Several technical and nontechnical improvements in peritoneal dialysis (PD) have occurred during recent years. Since few previous studies have examined trends in PD mortality over time, and to determine whether enhancements in PD have translated into improved patient outcomes, mortality rates among the 17,900 patients receiving PD in Canada during the period 1981-1997 were analyzed. Mortality rate ratios (RR) were estimated using Poisson regression, adjusting for age, race, gender, primary renal diagnosis, follow-up time, and type of PD (continuous ambulatory/cyclic versus intermittent). Adjusted mortality rates decreased significantly by calendar period, the reduction being monotonic: RR = 0.81, 95% confidence interval [CI], 0.75 to 0.87 for 1986-1989; RR = 0.73, 95% CI, 0.67 to 0.78 for 1990-1993; RR = 0.63, 95% CI, 0.58 to 0.67 for 1994-1997, with 1981-1985 serving as the reference period (RR = 1, fixed). The improvement in mortality was fairly consistent across patient subpopulations. When analyzed separately by follow-up time window, the mortality decrease was strongest in the first 12 mo after renal replacement therapy initiation. Supplementary analysis revealed that the trend in mortality rates was not attributable to corresponding trends in transplantation or technique failure rates, or modality switching patterns. Results were quite similar whether based on an "as-treated" or "intent-to-treat" analysis. More extensive data on practice patterns would empower future studies to elucidate the cause/effect relationship between PD practice patterns and patient survival.

Entities:  

Mesh:

Year:  2000        PMID: 10616848     DOI: 10.1681/ASN.V111126

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  5 in total

1.  Patient outcome in primary peritoneal dialysis patients versus those transferred from hemodialysis and transplantation.

Authors:  Iraj Najafi; Mostafa Hosseini; Shahnaz Atabac; Hushang Sanadgol; Nader Nouri Majelan; Shiva Seirafian; Massih Naghibi; Khadigeh Makhdoumi; Fereshteh Saddadi; Tayebeh Soleymanian
Journal:  Int Urol Nephrol       Date:  2011-11-17       Impact factor: 2.370

2.  Trends in mortality and graft failure for renal transplant patients.

Authors:  Douglas E Schaubel; John R Jeffery; Yang Mao; Robert Semenciw; Karen Yeates; Stanley S A Fenton
Journal:  CMAJ       Date:  2002-07-23       Impact factor: 8.262

Review 3.  Can peritoneal dialysis be used as a long term therapy for end stage renal disease?

Authors:  Michele Giannattasio; Michele Buemi; Flavia Caputo; Giusto Viglino; Enrico Verrina
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

Review 4.  Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in peritoneal dialysis patients.

Authors:  Ling Zhang; Xiaoxi Zeng; Ping Fu; Hong Mei Wu
Journal:  Cochrane Database Syst Rev       Date:  2014-06-23

5.  Peritoneal dialysis in diabetics: there is room for more.

Authors:  P Cotovio; A Rocha; A Rodrigues
Journal:  Int J Nephrol       Date:  2011-10-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.